Authorities recalculate medicine prices under revised regulations. Reductions affected thousands of regulated product lines, though the 76 per cent figure refers to comparing 2025 maximum price limits with benchmarks approved in late 2024.
The Central Communications Service under the President of Kazakhstan published these metrics on 28 September, citing the Ministry...